Kabra Drugs Limited is engaged in the business of Permaculture manufacturing and trading in pharma related products.Product Profile: a) Cardiovascular Drugs b) Anti-infective Drugs c) Oncology Drugs d) Gastroenterological Drugs e) Hormonal Drugs f) Miscellaneous Drugs g) Active Pharmaceutical Ingredients
Kabra Drugs Limited has announced a certificate from its Registrar & Share Transfer Agent, M/s Skyline Financial Services Pvt Ltd, confirming compliance related to its shareholding pattern for the quarter ended June 30, 2025. This attestation ensures the accuracy and proper maintenance of the company's dematerialized share records, supporting transparency...
Kabra Drugs Limited has announced a board meeting to approve the financial results for the quarter and half-year. The company has also made public the audited financial results for the quarter and year ended March 31, 2025, through advertisements in both English and Hindi newspapers. This disclosure ensures transparency and...
Kabra Drugs Limited has clarified that it is exempt from submitting the Annual Secretarial Compliance Report due to its paid-up equity share capital of approximately Rs. 23.7 crore and net worth below Rs. 3.28 crore. This exemption relieves the company from certain corporate governance provisions, reflecting its smaller scale of...
Kabra Drugs Limited has submitted a certificate for the quarter ended March 31, 2025, confirming compliance with SEBI regulations as provided by their Registrar and Share Transfer Agent, Skyline Financial Services. This compliance reflects the company's adherence to operational standards required for maintaining shareholder records. While this update is procedural,...
